PulsePoint Launches the First Centralized Data Activation and Measurement Technology Built Specifically for Health
NEW YORK--(BUSINESS WIRE)--May 15, 2018--PulsePoint, the leading global authority in programmatic healthcare technology, today announced the launch of Genome by PulsePoint™, the most comprehensive integrated health data solution in the market. Genome unifies clinical and real-world data from best-in-class data vendors to create a unique and precise view on consumers, patients and healthcare professional (HCP), and uses AI to refine and improve learnings.
“Until now, the market’s approach to data has been generic and fragmented, whereby if a health marketer wanted to activate a specific audience, they’d have to work with several data partners. Genome solves this marketplace need by providing the technology to unify, understand and activate all data points relevant to drive outcomes,” said Ezra Suveyke, Chief Technology Officer at PulsePoint.
By combining health and non-health data signals with proprietary online behavioral data and AI, Genome gives health marketers the power to find, understand and influence the patients and physicians they are looking for, no matter how small or niche the population. Marketers can activate their first party data, or target the patient or HCP by custom segment and sub-segment, and in some cases, at the individual level.
Genome is channel agnostic, currently being used to reach and measure the efficacy of health messaging in the US market. All patient data is de-identified by data partners prior to being on-boarded into Genome. It is currently available to the US market.
PulsePoint’s goal is to make the customer the center of all health marketing. “Everyone is talking about customer-centricity, but to do this, you have to know your customer—who they are, where they are, and what they’re looking for. And you have to be able to deliver relevant experiences to them that drive real benefit, for them and for the marketer, ” said Sloan Gaon, CEO of PulsePoint. “With Genome, PulsePoint is breaking down the barriers between customer knowledge, customer experiences, marketing impact and health outcomes to achieve radical health personalization.”
For more information on how to create Genome datasets, please email Yeehooi Tee at firstname.lastname@example.org.
PulsePoint, a global programmatic advertising platform with specialized healthcare expertise, fuses the science of programmatic targeting, distribution and optimization with the art of brand engagement. The PulsePoint platform is powered by terabytes of impression-level data, allowing brands to efficiently engage the right audiences at scale while helping publishers increase yield through actionable insights. Investors in the company include Draper Fisher Jurvetson (DFJ), Gotham Ventures, New Atlantic Ventures (NAV), Patricia Industries, Updata Partners and VantagePoint Capital Partners. The company is headquartered in New York City with offices in San Francisco, California, and London, U.K. Learn more about PulsePoint here.
View source version on businesswire.com:https://www.businesswire.com/news/home/20180515005323/en/
CONTACT: For PulsePoint
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT PRACTICE MANAGEMENT HEALTH CLINICAL TRIALS COMMUNICATIONS ADVERTISING MARKETING MANAGED CARE
Copyright Business Wire 2018.
PUB: 05/15/2018 09:00 AM/DISC: 05/15/2018 09:01 AM